Flow Pharma, Inc. — Form D

Flow Pharma, Inc. of WARRENSVILLE HEIGHTS, OH, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-02. The offering totals $10.5M, of which $180K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Stephen Martin FarrDirectorWarrensville Heights, OH
Babatunde Vincent OtulanaDirectorWarrensville Heights, OH
Pamela Vincent SteeleDirectorWarrensville Heights, OH
Thomas Martin BarnishExecutive OfficerWarrensville Heights, OH
Tom Martin BradyExecutive OfficerWarrensville Heights, OH
Charles Vincent HerstExecutive OfficerWarrensville Heights, OH
Gil Martin Van BokkelenExecutive OfficerWarrensville Heights, OH
Pamela Martin SteeleDirectorWarrensville Heights, OH
Anthony Martin TufaroDirectorWarrensville Heights, OH
Reid Martin RubsamenDirectorWarrensville Heights, OH
Reid Martin RubsamenExecutive OfficerWarrensville Heights, OH
Tikoes Martin BlankenbergDirectorWarrensville Heights, OH
Babatunde Martin OtulanaDirectorWarrensville Heights, OH
Lester J LloydDirectorOrinda, CA
Lester J LloydExecutive OfficerOrinda, CA
Lester John LloydDirectorOrinda, CA
Lester John LloydExecutive OfficerOrinda, CA
Reid Michael RubsamenDirectorAlamo, CA
Reid Michael RubsamenExecutive OfficerAlamo, CA
Thomas John BradyExecutive OfficerSierra Madre, CA
Reid M RubsamenDirectorAlamo, CA
Reid M RubsamenExecutive OfficerAlamo, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2024-08-08D/A$40.0M$225K
2024-08-01D$40.0M$50K
2018-02-28D$2.3M
2018-02-28D$1.1M

More